世界の末梢塞栓防止装置市場:医療機器パイプライン分析2016

◆英語タイトル:Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0240EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年11月1日
◆ページ数:87
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、末梢塞栓防止装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・末梢塞栓防止装置の概要
・末梢塞栓防止装置の開発動向:開発段階別分析
・末梢塞栓防止装置の開発動向:セグメント別分析
・末梢塞栓防止装置の開発動向:領域別分析
・末梢塞栓防止装置の開発動向:規制Path別分析
・末梢塞栓防止装置の開発動向:承認日(推定)別分析
・企業別末梢塞栓防止装置の開発動向(パイプライン製品、進行中の治験)
・末梢塞栓防止装置の最近動向
【レポートの概要】

Peripheral Embolic Protection Devices – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Peripheral Embolic Protection Devices – Medical Devices Pipeline Assessment, 2016″ provides an overview of Peripheral Embolic Protection Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Embolic Protection Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Peripheral Embolic Protection Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Peripheral Embolic Protection Devices Overview 7
3 Products under Development 8
3.1 Peripheral Embolic Protection Devices – Pipeline Products by Stage of Development 8
3.2 Peripheral Embolic Protection Devices – Pipeline Products by Segment 9
3.3 Peripheral Embolic Protection Devices – Pipeline Products by Territory 10
3.4 Peripheral Embolic Protection Devices – Pipeline Products by Regulatory Path 11
3.5 Peripheral Embolic Protection Devices – Pipeline Products by Estimated Approval Date 12
3.6 Peripheral Embolic Protection Devices – Ongoing Clinical Trials 13
4 Peripheral Embolic Protection Devices – Pipeline Products under Development by Companies 14
4.1 Peripheral Embolic Protection Devices Companies – Pipeline Products by Stage of Development 14
4.2 Peripheral Embolic Protection Devices – Pipeline Products by Stage of Development 15
5 Peripheral Embolic Protection Devices Companies and Product Overview 16
5.1 Abbott Vascular Inc. Company Overview 16
5.1.1 Abbott Vascular Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Avantec Vascular Corporation Company Overview 18
5.2.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 Cardio-Flow Ltd. Company Overview 19
5.3.1 Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 19
5.4 CardioGard Ltd. Company Overview 20
5.4.1 CardioGard Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 Claret Medical, Inc. Company Overview 23
5.5.1 Claret Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 EKOS Corporation Company Overview 26
5.6.1 EKOS Corporation Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 EMBA Medical Limited Company Overview 32
5.7.1 EMBA Medical Limited Pipeline Products & Ongoing Clinical Trials Overview 32
5.8 Inari Medical, Inc. Company Overview 35
5.8.1 Inari Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.9 Innovative Cardiovascular Solutions, LLC Company Overview 38
5.9.1 Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 38
5.10 Innovia LLC Company Overview 40
5.10.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 40
5.11 Keystone Heart Ltd. Company Overview 41
5.11.1 Keystone Heart Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41
5.12 Medtronic plc Company Overview 45
5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 45
5.13 Metactive Medical, LLC Company Overview 47
5.13.1 Metactive Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 47
5.14 MIV Therapeutics Inc Company Overview 48
5.14.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 48
5.15 Neurosonix Ltd. Company Overview 49
5.15.1 Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49
5.16 Trinity College Dublin Company Overview 50
5.16.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 50
5.17 University of Minnesota Company Overview 51
5.17.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 51
5.18 University of Toledo Company Overview 52
5.18.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 52
6 Peripheral Embolic Protection Devices- Recent Developments 54
6.1 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 54
6.2 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 54
6.3 Oct 03, 2016: American Journal of Cardiology Reports Data Showing New Brain Lesions in 94% of Patients Following TAVR 55
6.4 Sep 20, 2016: Claret Medical Submits Marketing Application to FDA for US Clearance of First Cerebral Protection System for Transcatheter Aortic Valve Replacement (TAVR) 56
6.5 Sep 19, 2016: TriGuard Cerebral Protection Device Demonstrates Safety and Significant Improvements in Brain Protection in Patients Undergoing TAVR Procedures 57
6.6 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 58
6.7 Sep 14, 2016: Claret Medical Announces SENTINEL Pivotal IDE Trial to Be Featured in Late-Breaking Trial Session at Transcatheter Cardiovascular Therapeutics (TCT) Conference 59
6.8 Aug 30, 2016: MPSC Announces 2016 Interim Results 60
6.9 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 61
6.10 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results 64
6.11 Aug 01, 2016: AngioDynamics to Raise Funds through Public Offering of Shares 64
6.12 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 65
6.13 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results 66
6.14 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 68
6.15 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 68
6.16 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 69
6.17 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 70
6.18 Jun 15, 2016: Keystone Heart Announces First Patient Enrolled in New Study to Protect the Brain During TAVR 70
6.19 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 71
6.20 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 72
6.21 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 72
6.22 May 31, 2016: Keystone Heart Appoints New President and Chief Executive Officer 75
6.23 May 19, 2016: TriGuard Cerebral Protection Device Shows Reduction in Stroke Rate and Improvement in Patients’ Neurological Outcomes in TAVR Procedures 75
6.24 May 09, 2016: Penumbra Reports First Quarter 2016 Financial Results 76
6.25 Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results 76
6.26 Mar 31, 2016: Penumbra to Present Final Results of Multicenter Prism Trial on Indigo System at SIR 2016 78
6.27 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device 78
6.28 Mar 08, 2016: Inari Medical Announces IDE Approval To Study The Flowtriever System For The Treatment Of Pulmonary Embolism 78
6.29 Feb 02, 2016: EndoShape Raises USD7 Million in Venture Financing 79
6.30 Jan 06, 2016: Penumbra Introduces POD Packing Coil for the Embolization of Peripheral Vessels and Aneurysms 79
6.31 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved 80
6.32 Dec 23, 2015: MicroPort Completed the First Distant Interactive Surgery in the Field of Coronary Interventional Treatment 80
6.33 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International Conference 81
6.34 Nov 23, 2015: Inari Medical And Inceptus Medical Announce Receipt Of TCT Innovation Award 82
6.35 Nov 18, 2015: EMBA Medical Cleared to Market Hourglass Peripheral Embolization Plug in New Zealand 82
7 Appendix 84
7.1 Methodology 84
7.2 About GlobalData 86
7.3 Contact Us 86
7.4 Disclaimer 87

1.1 List of Tables
Table 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 8
Table 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment 9
Table 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory 10
Table 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path 11
Table 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date 12
Table 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials 13
Table 7: Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development 14
Table 8: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 15
Table 9: Abbott Vascular Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
Table 10: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status 16
Table 11: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description 17
Table 12: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
Table 13: Peripheral Embolization Device - Product Status 18
Table 14: Peripheral Embolization Device - Product Description 18
Table 15: Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 16: EmboPRO EPD - Product Status 19
Table 17: EmboPRO EPD - Product Description 19
Table 18: CardioGard Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 19: CardioGard 22 French Aortic Cannula - Product Status 20
Table 20: CardioGard 22 French Aortic Cannula - Product Description 20
Table 21: CardioGard Ltd. - Ongoing Clinical Trials Overview 21
Table 22: CardioGard 22 French Aortic Cannula - A Study to Collect Additional Information Related to the Performance of the CARDIOGARD Cannula 22
Table 23: Claret Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 24: Sentinel Cerebral Protection System - Product Status 23
Table 25: Sentinel Cerebral Protection System - Product Description 23
Table 26: Claret Medical, Inc. - Ongoing Clinical Trials Overview 24
Table 27: Sentinel Cerebral Protection System - Cerebral Protection in Transcatheter Aortic Valve Replacement - The SENTINEL Study 25
Table 28: Sentinel Cerebral Protection System - Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve Replacement 25
Table 29: Sentinel Cerebral Protection System - PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection with the Claret Sentinel Device 25
Table 30: EKOS Corporation Pipeline Products & Ongoing Clinical Trials Overview 26
Table 31: EkoSonic Endovascular System - Product Status 26
Table 32: EkoSonic Endovascular System - Product Description 27
Table 33: EkoSonic Endovascular System - Control Unit - Product Status 27
Table 34: EkoSonic Endovascular System - Control Unit - Product Description 28
Table 35: EKOS Corporation - Ongoing Clinical Trials Overview 29
Table 36: EkoSonic Endovascular System - Accelerated Thrombolysis for Post-thrombotic Syndrome Using EKOS 30
Table 37: EkoSonic Endovascular System - Study of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in the Treatment of Acute Submassive Pulmonary Embolism 30
Table 38: EkoSonic Endovascular System - Submassive Pulmonary Embolism Experience with EKOS 31
Table 39: EkoSonic Endovascular System - Usefulness and Safety of Ultrasound-assisted Catheter-directed Thrombolysis for Submassive Pulmonary Emboli 31
Table 40: EMBA Medical Limited Pipeline Products & Ongoing Clinical Trials Overview 32
Table 41: Hourglass Peripheral Embolization Plug - Product Status 32
Table 42: Hourglass Peripheral Embolization Plug - Product Description 32
Table 43: EMBA Medical Limited - Ongoing Clinical Trials Overview 33
Table 44: Hourglass Peripheral Embolization Plug - EMBA Peripheral Embolization Device (EPED) Study 34
Table 45: Inari Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 46: FlowTriever System - Pulmonary Embolism - Product Status 35
Table 47: FlowTriever System - Pulmonary Embolism - Product Description 35
Table 48: Inari Medical, Inc. - Ongoing Clinical Trials Overview 36
Table 49: FlowTriever System - Pulmonary Embolism - FlowTriever Pulmonary Embolectomy Clinical Study 37
Table 50: Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 38
Table 51: Emblok Embolic Protection Catheter - Product Status 38
Table 52: Emblok Embolic Protection Catheter - Product Description 39
Table 53: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 40
Table 54: Permanently Implantable Embolic Balloon - Product Status 40
Table 55: Permanently Implantable Embolic Balloon - Product Description 40
Table 56: Keystone Heart Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 57: TriGuard Cerebral Protection Device - Product Status 41
Table 58: TriGuard Cerebral Protection Device - Product Description 42
Table 59: Keystone Heart Ltd. - Ongoing Clinical Trials Overview 43
Table 60: TriGuard Cerebral Protection Device - A Prospective, Single Arm Feasibility Study to Evaluate the Safety and Performance of the SMT Embolic Deflection Device in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR) 44
Table 61: TriGuard Cerebral Protection Device - A Randomized Evaluation of the TriGuard Embolic Deflection Device to Reduce the Impact of Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation 44
Table 62: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 63: SilverHawk With SpiderFX Embolic Protection Device - Product Status 45
Table 64: SilverHawk With SpiderFX Embolic Protection Device - Product Description 46
Table 65: Metactive Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 47
Table 66: Blockstent Microcatheter - Product Status 47
Table 67: Blockstent Microcatheter - Product Description 47
Table 68: MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 69: Aortic Embolic Protection Device - Product Status 48
Table 70: Aortic Embolic Protection Device - Product Description 48
Table 71: Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49
Table 72: Protection Collar - Product Status 49
Table 73: Protection Collar - Product Description 49
Table 74: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 50
Table 75: Transcatheter Device - Atherosclerotic Plaque - Product Status 50
Table 76: Transcatheter Device - Atherosclerotic Plaque - Product Description 50
Table 77: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 51
Table 78: Embolic Protection Device - Product Status 51
Table 79: Embolic Protection Device - Product Description 51
Table 80: University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 52
Table 81: Minimally Invasive Thrombectomy Device - Product Status 52
Table 82: Minimally Invasive Thrombectomy Device - Product Description 53
Table 83: Glossary 85

1.2 List of Figures
Figure 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 8
Figure 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment 9
Figure 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory 10
Figure 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path 11
Figure 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date 12
Figure 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials 13

【掲載企業】

Abbott Vascular Inc.
Avantec Vascular Corporation
Cardio-Flow Ltd.
CardioGard Ltd.
Claret Medical, Inc.
EKOS Corporation
EMBA Medical Limited
Inari Medical, Inc.
Innovative Cardiovascular Solutions, LLC
Innovia LLC
Keystone Heart Ltd.
Medtronic plc
Metactive Medical, LLC
MIV Therapeutics Inc
Neurosonix Ltd.
Trinity College Dublin
University of Minnesota
University of Toledo

【レポートのキーワード】

末梢塞栓防止装置

★調査レポート[世界の末梢塞栓防止装置市場:医療機器パイプライン分析2016] (コード:GDME0240EPD)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の末梢塞栓防止装置市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆